ADHD Slows Speech in Poor Hearing: Evidence from Eye Movements

Published Date: 02 Mar 2023

A new study by Prof. Boaz Ben-David and Rony Lemel of Reichman University's Baruch Ivcher School of Psychology has found that attention deficit hyperactivity disorder (ADHD) causes slow and difficult understanding of words.

Read Full News

Latest News

Recurrent UTIs Within 6 Months May Signal Cancer Risk

Individuals presenting with repeated UTIs experience longer diagnostic delays and poorer outcomes than those presenting with hematuria.

Acute Liver Failure: 5 Things to Know

Acute liver failure requires rapid recognition and intervention, with delays associated with significantly increased mortality risk.

New Data: US Psilocybin Use Reaches 8 Million

About 8 million people in the US use psilocybin, which is linked to depression, alcohol use disorder, cannabis use, and prescription drug misuse, a new study shows.

What’s Really Going on in Aging Tendons and Ligaments

Staying active your whole life means avoiding injury. Connective tissue may not get the same love muscles do but these strategies can mitigate risk.

Genotype-Guided SSRI Prescribing Offers Mixed Results

Use of genotype-guided SSRI shows no symptom improvement at 3 months in people with depression but is linked to higher remission rates at 6 months.

CGRP Inhibitors for Migraine Linked to Reduced Glaucoma Risk

The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for glaucoma than the use of non-CGRP inhibitors, a new study shows.

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Latest News

Individuals presenting with repeated UTIs experience longer diagnostic delays and poorer outcomes than those presenting with hematuria.

Acute liver failure requires rapid recognition and intervention, with delays associated with significantly increased mortality risk.

About 8 million people in the US use psilocybin, which is linked to depression, alcohol use disorder, cannabis use, and prescription drug misuse, a new study shows.

Staying active your whole life means avoiding injury. Connective tissue may not get the same love muscles do but these strategies can mitigate risk.

Use of genotype-guided SSRI shows no symptom improvement at 3 months in people with depression but is linked to higher remission rates at 6 months.

The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for glaucoma than the use of non-CGRP inhibitors, a new study shows.

News All Time

Tegoprazan TRIUMpHs Over PPI For Erosive Esophagitis

Tegoprazan is superior to the proton pump inhibitor lansoprazole for healing erosive esophagitis as early as week 2, but one expert finds these results underwhelming.

Q&A: Progress in Thwarting ‘Chemobrain’

Recent trials suggest that simple steps during chemotherapy — including moderate exercise and a daily ibuprofen — may lessen treatment-related cognitive symptoms.

Second Cancer Rates Vary Widely Among Survivors

Not all cancer survivors face the same likelihood for a second cancer. New data show striking differences by age, cohort, and initial diagnosis.

A Verdict on Low-Dose Lithium for Cognitive Preservation?

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to preserve cognitive function. It didn’t.

Digital NHS Risks Leaving Older Patients Behind

Older people lack the skills, devices, or support to book GP appointments online — and many are giving up on trying.

FDA Authorizes First Fruit-flavored E-cigarettes in US Amid Political Pressure

The U.S. Food and Drug Administration on Tuesday allowed the marketing of fruit-flavored e-cigarettes ⁠in a first authorization of non-tobacco-flavored vaping products, amid...

What About the Bone Effects of GLP-1 Receptor Agonists?

GLP-1 receptor agonists do not appear to increase fracture risk at diabetes doses, but caution may be needed with higher obesity doses and rapid weight loss

Cervical Cancer Screening Gaps Persist After 65 Years of Age

Most women requiring continued cervical cancer screening — including those at high risk — do not continue screening after 65 years of age.

CME-Based Board Certification Path Gains Ground

A CME-based certification option is attracting increasing interest as physicians and specialty groups weigh alternatives to traditional maintenance-of-certification models.

Sudden Headache During Sexual Activity: A Vascular Cause?

Headaches during sexual activity require prompt evaluation to exclude subarachnoid hemorrhage or reversible cerebral vasoconstriction syndrome.

Novel Cell Therapy Shows Promise in Resistant TLE

A novel cell therapy is safe and effective in patients with drug-resistant mesial temporal lobe epilepsy and could eventually offer an alternative intervention.

AI Scribes’ Notes Show Quality Gaps vs Human Output

In an assessment of five scenarios in primary care, clinical notes generated by AI exhibited lower quality scores than those produced by human clinicians.

Budesonide Should Be Taken Continuously for EoE Remission

Research favors continuous treatment for eosinophilic esophagitis vs intermittent therapy, underlining the need to counsel patients on optimal adherence.

Robotic Colonoscopy System Poised for the Clinic

A first-in-human trial of a robotic colonoscopy shows the system can perform all functions of a colonoscope with promising results and less wear and tear on colonoscopists.

UK Leads Global Bird Flu Vaccine Trial

The UK will provide three-quarters of the volunteers for an international mRNA vaccine trial against H5N1 bird flu, with 26 recruitment sites across the country.

Acetylcholinesterase Inhibitors May Lower Risk for Delirium

The continuous use of acetylcholinesterase inhibitors may reduce the risk for delirium in patients with dementia.

Recommended News For You

From Pathology to Precision: The Story of Leukemia Therapy

Increased Exercise May Lower the Risk of Prostate Cancer.

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

Recommended Articles For You

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances 

Neutrophil Profiling and AI Rewrites Cancer Diagnosis 

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases 

Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

2.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

3.

Clinical trial is testing whether heavy lifting could combat cancer side effects

4.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

5.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

1.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

2.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

3.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

4.

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology

5.

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XIII

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

3.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot